Factors Driving the Asia-Pacific Sleep Apnea Implants Market

Published: Jun 2021

The Asia-Pacific sleep apnea market is anticipated to grow at a CAGR of 8.2% during the forecast period (2021-2027). The market in the region is largely driven by the growing prevalence of sleep disordes such as sleep apnea due to the increasing workplace stress and depression. According to the IHME, the share of the population with depression ranges mostly between 2% and 5% across Asia-Pacific in 2017. Australia has one of the highest % of populations with depression where 4.62% of people are suffering from depression. Further, the prevalence of anxiety and schizophrenia is also high in Australia where schizophrenia accounts for 0.36% of the population and anxiety accounts for 6.58% of the population according to IHME. 

Browse the full report description Asia-Pacific Sleep Apnea Implants Market Size, Share & Trends Analysis Report By Type (Hypoglossal Neurostimulation Devices, Phrenic Nerve Stimulator, Palatal Implants), By Indication Type (Obstructive Sleep Apnea, Central Sleep Apnea), By End-User (Hospitals & Clinics, Home Care) Forecast Period 2021-2027 at https://www.omrglobal.com/industry-reports/asia-pacific-sleep-apnea-implants-market

These increasing numbers of mental disorders across Asia-Pacific are increasing the incidences of sleep apnea among the patients. The Asia-Pacific sleep apnea implants market presents future opportunities for growth as the prevalence of sleep disorders such as sleep apnea and insomnia in emerging economies such as India, Australia, and China. In addition, increasing the geriatric population specially in Japan is another major reason for the growing market. Japan’s Ministry of Health, Labour and Welfare have approved Inspire Medical Systems Inc’s Inspire therapy for the treatment of severe to moderate OSA in 2019. The approval of such treatment therapy is again aiding to the market growth.

Market Coverage

  • The market number available for – 2020-2027
  • Base year- 2020
  • Forecast period- 2021-2027
  • Segment Covered- 

o By Type

o By Indication Type

o By End-User

  • Competitive Landscape- 3B Medical, Inc., Circadiance LLC., Invacare Corp., ResMed Inc., Somnetics International, Inc., and so on.

Key questions addressed by the report

  • What is the market growth rate?
  • Which segment and region dominate the market in the base year?
  • Which segment and region will project the fastest growth in the market?
  • How COVID-19 impacted the market?

o Deviation from the pre-COVID-19 forecast

o Most affected region and segment

  • Who is the leader in the market?
  • How players are addressing challenges to sustain growth?
  • Where is the investment opportunity?

Asia-Pacific Sleep Apnea Implants Market Report Segment

By Type 

  • Hypoglossal Neurostimulation Devices
  • Phrenic Nerve Stimulator 
  • Palatal Implants 

By Indication Type

  • Obstructive Sleep Apnea
  • Central Sleep Apnea

By End-User

  • Hospitals & Clinics
  • Homecare

Asia-Pacific Sleep Apnea Implants Market Report Segment by Region

  • China
  • India
  • Japan 
  • South Korea
  • Rest of Asia-Pacific 

To learn more about this report request a free sample copy @ https://www.omrglobal.com/request-sample/asia-pacific-sleep-apnea-implants-market